Tackling Neuroinflammation to Reduce Pathological Brain Changes in Alzheimer’s Patients with Dr. R.J. Tesi INmune Bio TRANSCRIPT
Download PDFApr 26, 2021
Dr. R.J. Tesi, President and CEO, INmune Bio shines light on the complexity of the immune system by pointing out that while much work has been done on the adaptive immune system, the key to treating Alzheimer's might be to address the dysregulated innate immune system due to chronic inflammation. R.J. talks about...
Apr 26, 2021
Dr. R.J. Tesi, President and CEO, INmune Bio shines light on the complexity of the immune system by pointing out that while much work has been done on the adaptive immune system, the key to treating Alzheimer's might be to address the dysregulated innate immune system due to chronic inflammation. R.J. talks about...
Treating Alzheimer’s and Parkinson’s by Addressing Axonal Transport to Protect Nerve Cells from Dying with Maria Maccecchini Annovis Bio TRANSCRIPT
Download PDFApr 20, 2021
Maria Maccecchini PhD, Founder, President, CEO, Annovis Bio has been on the path to find a way to protect nerve cells to maintain overall health. Lead therapy ANVS401 (phase 2) is designed to treat Alzheimer's, Parkinson's and other neurodegenerative diseases by tapping into the brain's defense mechanism to get rid of...
Apr 20, 2021
Maria Maccecchini PhD, Founder, President, CEO, Annovis Bio has been on the path to find a way to protect nerve cells to maintain overall health. Lead therapy ANVS401 (phase 2) is designed to treat Alzheimer's, Parkinson's and other neurodegenerative diseases by tapping into the brain's defense mechanism to get rid of...
Treating Schizophrenia by Mitigating Peripheral Side Effects from Existing Antipsychotics with Dr. Stephen Brannan Karuna Therapeutics TRANSCRIPT
Download PDFApr 7, 2021
Dr. Stephen Brannan, Chief Medical Officer, Karuna Therapeutics discusses the need for creating and delivering transformative medicines for people living with psychiatric and neurological conditions particularly schizophrenia. Pairing the muscarinic agonist with a pan-cholinergic antagonist that does not cross into the...